Baxter International Inc. - SWOT, Strategy and Corporate Finance Report
Baxter International Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.
Detailed information on Baxter International Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Baxter International Inc. in the form of a SWOT analysis
An in-depth view of the business model of Baxter International Inc. including a breakdown and examination of key business segments
Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Baxter International Inc.
Intelligence on Baxter International Inc.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Baxter International Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Baxter International (Baxter or 'the company') is engaged in the development, manufacture and marketing of products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in North America, Europe, Asia Pacific and Latin America. It is headquartered in Deerfield, Illinois and employed about 51,000 people as of December 31, 2012. The company recorded revenues of $14,190 million during the financial year ended December 2012 (FY2012), an increase of 2.1% over FY2011. The operating profit of the company was $2,821 million* in FY2012, a decrease of 4.2% over FY2011. The net profit was $2,326 million in FY2012, an increase of 4.6% over FY2011. *Income before net interest expense, other income and income taxes.
Reasons to Purchase:
Gain understanding of Baxter International Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Baxter International Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Baxter International Inc.’s business structure, strategy and prospects